Rapid Agricultural Response Fund
To find a new way to problem solve in the 21st century, in 1998 the Minnesota Legislature worked with the state's agricultural leaders to create resources to tackle emerging agrilcultural challanges. The result was the Rapid Agricultural Response Fund (RARF). Since that beginning it has helped develop research answers to some of the most puzzling and unpredictable problems facing our farmers.
Below you will find overviews of the most recent RARF projects including background information, project objectives, and progress updates when available.
Dr. Pieters and her partners are working to characterize the detection of M. hyopneumoniae in processing fluids (PF), identify probable sources of the bacterium, and to evaluate the potential use of PF in M. hyopneumoniae monitoring and surveillance programs.
Dr. Vannucci and his partners are working to determine the impact of biosecurity procedures on the transmission and spread of Senecavirus A between pig populations.
Sinisa Vidovic and his team are working to develop a live, attenuated vaccine against critical outer membrane proteins (OMPs), which can prevent Salmonella colonization of chickens and turkeys.
Brian Steffenson and his team are working to develop barley varieties that are resistant to Bacterial Leaf Streak, thereby ameliorating the losses due to this significant disease.
Lindsey Pease and her team are working to update and revise the Minnesota Phosphorus Site Risk Index (MNPI) tool. The MNPI must be updated to correspond with a recent policy change by the USDA Natural Resources Conservation Service regarding how erosion is predicted across landscapes.
Dr. Pieters and her partners are investigating the role of antimicrobial resistance on Mycoplasma eradication, to generate a PCR based test for M. hyopneumoniae selected antimicrobial susceptibility, and to evaluate the predictive value of the test in eradication success.
Krishona Martinson and her team are working to demonstrate equine carcass composting using affordable and readily available materials and Extension education with the aim of encouraging industry-wide adoption.
Sunil Kumar Mor and his team are studying the evolution and genomic constellations of newly re-emerging, lameness-associated turkey arthritis reoviruses (TARV) with a view to develop highly sensitive and specific diagnostic assays and to develop and evaluate safe and effective vaccines.
Abby Neu and her team are evaluating the delivery pathways for educational materials, workshops, and assistance for poultry producers related to biosecurity. By exploring the reliability of existing communication strategies they hope to discover gaps in communications and, ultimately, find new communications solutions.
Dr. Ly and his partners are working to develop and test a new vaccine for Hemorrhagic enteritis virus. The new vaccine will be based on viral vaccine vector (Pichinde virus, PICV) a technology recently developed by their laboratory.